评估一种预测左乳腺癌辅助放疗患者心脏和左前降支动脉剂量新指标的价值
本研究回顾性分析单中心50例左乳腺癌保乳术后辅助放疗患者,比较Contact Heart、第4弓和第5弓三种距离指标预测深吸气屏气放疗需求的能力。结果显示第4弓指标在预测平均心脏剂量≥1.7 Gy方面准确性最高,是唯一在多因素分析中保持显著的预测因子,作者提出将其作为确定屏气放疗需求的实用工具,但需外部验证。
要点
- 第4弓距离指标预测平均心脏剂量≥1.7 Gy的准确性、敏感性和一致性最高。
- 第4弓是唯一在多因素分析中保持统计学显著的预测因子。
- 第5弓对心脏V25 Gy≥10 cm3未达统计学显著。
核心结论
- 作者提出一种新的「第4弓」距离指标,作为确定左乳腺癌辅助放疗标准切线照射患者是否需要深吸气屏气放疗的准确且实用的工具,并认为需在外部队列中进一步验证。
研究设计与样本
- 单中心回顾性研究,纳入50例接受保乳手术及乳腺辅助放疗的左乳腺癌患者,依据指南勾画左乳及危及器官,采用仰卧位自由呼吸CT生成切线计划,计算心脏剂量(平均心脏剂量、心脏V25 Gy)和左前降支动脉剂量,并与Contact Heart、第4弓、第5弓三种距离指标进行比较,采用递归分割分析确定距离指标的最佳切点,用受试者工作特征曲线和Pearson相关系数评估关联,并行单因素和多因素logistic回归分析。
主要发现
- 平均平均心脏剂量为2.3 Gy,平均心脏V25 Gy为10.4 cm3。
- 采用切线照射时,平均心脏剂量<1.7 Gy和心脏V25 Gy<10 cm3的约束分别在80%和46%的患者中无法达到。
- 递归分割分析确定的最佳阈值为Contact Heart 73 mm、第4弓7 mm、第5弓41 mm。
- 第4弓的总体准确性、敏感性、一致性指数和相关系数最高。
- 单因素logistic回归中所有指标均为平均心脏剂量≥1.7 Gy的统计学显著预测因子;第5弓对心脏V25 Gy≥10 cm3未达统计学显著;多因素分析中第4弓是唯一保持统计学显著的预测因子。
关键数值与推荐
- 平均心脏剂量约束<1.7 Gy在80%的患者中无法达到,心脏V25 Gy约束<10 cm3在46%的患者中无法达到。
- 递归分割分析最佳阈值:Contact Heart 73 mm、第4弓7 mm、第5弓41 mm。
临床怎么用
- 作者提出「第4弓」指标可作为确定左乳腺癌辅助放疗标准切线照射患者是否需要深吸气屏气放疗的准确且实用的工具,并认为需在外部队列中进一步验证。
局限性
- 原文结论指出需在外部队列中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart-sparing techniques are time and resource intensive, although not all patients require the use of these strategies. This study evaluates the performance of different distance metrics in predicting the need for breath-hold radiotherapy in left-sided breast cancer patients receiving adjuvant radiotherapy. METHODS: Fifty left-sided breast cancer patients treated with breast conserving surgery and adjuvant radiotherapy to the breast from a single institution were retrospectively studied. The left breast and organs at risk were contoured in accordance to guidelines and a plan with tangents was obtained using the free-breathing CT in supine position. Heart (mean heart dose (MHD), heart V25 Gy) and left anterior descending artery dosimetry were computed and compared against distance metrics under investigation (Contact Heart, 4th Arch and 5th Arch). Recursive partitioning analysis (RPA) was used to determine optimal cut-points for distance metrics for dosimetric end points. Receiver operating characteristic curves and Pearson correlation coefficients were used to evaluate the association between distance metrics and dosimetric endpoints. Univariable and multivariable logistic regression analysis was performed to identify significant predictors of dosimetric end points. RESULTS: The mean MHD and heart V25 Gy were 2.3 Gy and 10.4 cm3, respectively. With tangents, constraints for MHD (< 1.7 Gy and V25 Gy < 10 cm3) were unattainable in 80% and 46% of patients, respectively. Optimal RPA thresholds included: Contact Heart (73 mm), 4th Arch (7 mm) and 5th Arch (41 mm). Of these, the 4th Arch had the highest overall accuracy, sensitivity, concordance index and correlation coefficient. All metrics were statistically significant predictors for MHD ≥ 1.7 Gy based on univariable logistic regression. Fifth Arch did not reach significance for heart V25 Gy ≥ 10 cm3. Fourth Arch was the only predictor to remain statistically significant after multivariable analysis. CONCLUSIONS: We propose a novel "4th Arch" metric as an accurate and practical tool to determine the need for breath-hold radiotherapy for left-sided breast cancer patients undergoing adjuvant radiotherapy with standard tangents. Further validation in an external cohort is necessary.
引用
- Mendez LC, Louie AV, Moreno C, et al. Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast. Radiat Oncol. 2018. PMID: 29973243. doi:10.1186/s13014-018-1069-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。